Finance

Results: 27517-27528 of 39896

Keymed Biosciences Announces Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM

PR Newswire associated0

SEforALL Board approves term renewal of CEO Damilola Ogunbiyi

NEW TESTS TO IDENTIFY HEREDITARY CANCER RISKS TO BE LAUNCHED

54,000 Voices Ignored: EU Health Ministers' Flavour Ban Push Threatens Public Health and Democracy

Innovative Grid Boosting Technologies Needed to Bring Europe’s Decarbonisation Targets Within Reach, Says New Industry Report

PR Newswire associated0

Sixes Social Cricket Launches Latest Venue in Trinidad & Tobago with Franchise Partners Yay! Entertainment

PR Newswire associated0

Research at Breda University of Applied Sciences: Don't fall for the vacation paradox

INTRESO Highlights Sustainable Alternatives as EU Considers a Ban on Sulfuryl Fluoride

K2 International Launches K2 Rubicon Specialty

GIST Impact, a leading impact data and analytics provider, receives investment from UBS Next

Yellowstone Biosciences launches with £16.5 million to pioneer soluble bispecific TCR-based therapies for cancer

Fintech & Payment Innovators Invited to Enter Juniper Research’s Future Digital Awards 2024